InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc.

XERS Clue Score53
United States Fiscal year ends December CIK 0001867096
$10.48 +2.85% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $10.48 +411.22% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 21 Jun 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue20.2Operating income−83.5Net income−91.1Fiscal year 2021Revenue49.6 +146.0%Operating income−115.2Net income−122.7EPS, diluted−1.55Fiscal year 2022Revenue110.2 +122.3%Operating income−81.9Net income−94.7EPS, diluted−0.70Fiscal year 2023Revenue163.9 +48.7%Operating income−44.0Net income−62.3EPS, diluted−0.45Fiscal year 2024Revenue203.1 +23.9%Operating income−33.6Net income−54.8EPS, diluted−0.37Fiscal year 2025Revenue291.8 +43.7%Operating income24.9Net income0.6EPS, diluted0.00
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 20.2 49.6 110.2 163.9 203.1 291.8
Growth +146.0% +122.3% +48.7% +23.9% +43.7%
Operating income −83.5 −115.2 −81.9 −44.0 −33.6 24.9
Net income −91.1 −122.7 −94.7 −62.3 −54.8 0.6
Growth
EPS, diluted n/a −1.55 −0.70 −0.45 −0.37 0.00

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Operating margin−414.5%Net margin−452.2%Free cash flow margin−401.6%Fiscal year 2021Operating margin−232.2%Net margin−247.5%Free cash flow margin−194.8%Fiscal year 2022Operating margin−74.3%Net margin−85.9%Fiscal year 2023Operating margin−26.8%Net margin−38.0%Fiscal year 2024Operating margin−16.6%Net margin−27.0%Fiscal year 2025Operating margin8.5%Net margin0.2%
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −414.5% −232.2% −74.3% −26.8% −16.6% 8.5%
Net margin −452.2% −247.5% −85.9% −38.0% −27.0% 0.2%
Free cash flow margin −401.6% −194.8% n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−80.6Capital expenditure−0.4Free cash flow−80.9Fiscal year 2021Operating cash flow−95.5Capital expenditure−1.1Free cash flow−96.6Fiscal year 2022Operating cash flow−102.9Fiscal year 2023Operating cash flow−47.0Fiscal year 2024Operating cash flow−37.0Fiscal year 2025Operating cash flow28.6
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −80.6 −95.5 −102.9 −47.0 −37.0 28.6
Capital expenditure −0.4 −1.1 n/a n/a n/a n/a
Free cash flow −80.9 −96.6 n/a n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2020Cash37.6Total debt87.0Net cash (debt)−49.4Shareholders’ equity33.8Debt to equity2.58Fiscal year 2021Cash67.3Total debt88.1Net cash (debt)−20.8Shareholders’ equity95.2Debt to equity0.92Fiscal year 2022Cash122.0Total debt187.1Net cash (debt)−65.1Shareholders’ equity45.2Debt to equity4.14Fiscal year 2023Cash67.4Total debt190.9Net cash (debt)−123.5Shareholders’ equity−6.8Fiscal year 2024Cash71.6Total debt232.1Net cash (debt)−160.5Shareholders’ equity−29.6Fiscal year 2025Cash111.0Total debt220.3Net cash (debt)−109.3Shareholders’ equity13.7Debt to equity16.10
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 37.6 67.3 122.0 67.4 71.6 111.0
Total debt 87.0 88.1 187.1 190.9 232.1 220.3
Net cash (debt) −49.4 −20.8 −65.1 −123.5 −160.5 −109.3
Shareholders’ equity 33.8 95.2 45.2 −6.8 −29.6 13.7
Debt to equity 2.58 0.92 4.14 n/a n/a 16.10

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−80.6 −95.5 −102.9 −47.0 −37.0 28.6
Growth
1.5 1.3 1.4 1.5 1.2 1.3
Investment
−0.4 −1.1 n/a n/a n/a n/a
calc −80.9 −96.6 n/a n/a n/a n/a
Growth
calc n/a −1.22 n/a n/a n/a n/a
−27.4 98.0 34.5 −6.0 4.9 −0.7
Financing
126.1 27.2 127.5 −1.6 36.2 11.4

† The diluted share count jumps at 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.